$PMHS

Polomar Health Services, Inc. (PMHS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Polomar Health Services, Inc. (PMHS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-3.1 2 ex3-1.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF POLOMAR HEALTH SERVICES, INC., a Nevada corporation (Effective as of July 1, 2026) These Amended and Restated Bylaws (these “Bylaws”) of Polomar Health Services, Inc., a Nevada corporation (the “Corporation”), a

Original reporting
Published Jul 6, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$PMHS
Neutral
low confidence
Mentioned
$PMHS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PMHSNeutralLow
01

Why it matters

Based on the provided excerpt, the actionable content is governance documentation; without the specific executive/director changes and compensation terms, the trading signal is weak.

02

Market read

This is a governance/compensation update with no disclosed financial metrics in the provided text, so it is unlikely to drive a major repricing absent material executive details in the full exhibits.

03

What to watch

Traders should verify the full 8-K exhibits for named officer departures/elections and any quantified compensation/benefit changes; those details—not the bylaws boilerplate—would determine materiality.

Relevance 6/10Novelty 3/10Timing: Filed July 6, 2026 (after market close) via SEC 8-K Item 5.02.

Background

The filing is an SEC Form 8-K under Item 5.02 covering director/officer changes and compensatory arrangements, and it includes amended and restated bylaws effective July 1, 2026.

Company-level read

Ticker impact

$PMHSNeutralLow confidence
Context

Polomar Health Services filed an 8-K for director/officer departures and elections plus officer compensatory arrangements under Item 5.02.

Expected impact

Likely limited immediate impact unless the omitted exhibits specify material executive changes or compensation terms; otherwise treat as low-volatility governance noise.

Evidence & confidence

The excerpt shows amended bylaws effective July 1, 2026 and references Item 5.02, but does not include the specific names, departures, elections, or compensation figures that would drive a stronger trading reaction.

Market effects

Minimal—this is company-specific governance/compensation documentation with no sector-wide regulatory or operational change disclosed.

None indicated.

None indicated.

Counterpoint

If the missing portions of Item 5.02 include a CEO/CFO departure or materially different compensation tied to performance, the market reaction could be larger than the bylaws-only excerpt suggests.

Key entities

  • Polomar Health Services, Inc.

    Subject of the SEC 8-K; governance/officer changes and compensatory arrangements under Item 5.02.

Related articles

$PHOSMed

First Phosphate shareholders could see reduced dilution risk, Noble says after SERV news

First Phosphate Corp. (PHOS) may face reduced equity dilution after Noble Capital Markets noted potential lower funding needs for its Bégin-Lamarche project, supported by Swiss Export Risk Insurance (SERV) and other financing. SERV could provide up to US$212.5 million, reducing the equity requirement to about US$82.5 million. Noble maintains an Outperform rating and $25.50 price target.

$AONHighAI 9/10

Aon raises $13.75 billion to support USI acquisition

Aon raised $13.75 billion in senior notes, guaranteed by its subsidiaries, with maturities from 2029 to 2056 and coupons ranging from 5.350% to 6.450%. The funds, approximately $13.4 billion after expenses, will support the USI Advantage Corp. acquisition and general corporate purposes. The notes include redemption protections tied to the deal's completion.